Login

Brickability Group PLC Wins AIM 'Transaction of the Year Award | Alan Simpson - CEO of Brickability Gr 00:10:00

Share On Facebook Share On Twitter

Alan Simpson is the CEO of Brickability Gr

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Advancing Copper-Gold Development: Serengeti Resources' Path to Pre-Feasibility
00:10:00
Unlocking the Potential of Generative AI in Healthcare: Expert Perspectives and Innovations | A. Hadi Chaudhry, CEO, CareCloud Inc.
00:10:00
How has the market impacted investment & CISO buying strategies|Yoav Andrew Leitersdorf,Managing Partner,YL Ventures
00:10:00
4 Simple Steps to OT Security: Focus on Version Control and Backup | Tobias Antius, CEO at Novotek AB
00:10:00
A paradigm shift in cellularbased therapy for regenerative medicine|Karolis Rosickas,Chief Executive Officer,Regeneus
00:10:00
Intrepid Metals Corp CEO Ken Brophy discusses the company's move to OTCQB, progress on the Corral Copper project, and ambitious plans for exploration and expansion in Arizona's mining-rich regions.|Ken Brophy CEO of Intrepid Metals Corp.
00:10:00
David Berlinski on Scientific Overreach and the Myth of Global Warming
00:10:00
Bill CEO Talks Fintech for Small Businesses and Inflation Impact | René Lacerte - CEO of BILL
00:10:00
APOS 2023 Highlights feature Janice Lee, CEO of Viu and PCCW.
00:10:00
Preparing Heirs for Their Inheritance: Ensuring a Smooth Transition |Eric Lawton, President , Impact Financial.
00:10:00
Accumulating and Advancing Copper Assets: Insights from Leo Hathaway at One-to-One Mining Conference
00:10:00
"Dr. Dietmar Ley, CEO of Basler AG, shares insights on the company's growth trajectory and future outlook in an exclusive interview at the Deutsches Eigenkapitalforum."|The Basler AG management board is comprised of Dr. Dietmar Ley (CEO)

© 2026 Nehu